Skip to main content Skip to main navigation menu Skip to site footer


Medicinal plants have incredible importance because of the presence of many types of components present in it, and they become the source for the synthesis of active pharmaceutical ingredients (API). Calotropis procera is a xerophytic shrub, with soft, tall; numerous shrubs with small flowering branches or small trees belonging to the family of Asclepiadaceae, distributed globally over the tropical and subtropical region of Asia and Africa. It is well known in traditional medicine to have cleansing and anti-ageing properties as well as used in the mitigation of various ailments as antiulcer, anti-leprotic, cytotoxic, anti-emetic, anti-coagulant and anticancer activities. It contains various chemical constituents like cardiac glycoside, triterpens, flavanoids, steroids and other phenolic components in various parts of plant was well known for its diverse pharmacological and biological activities. Different extracts of plant and parts of plants possess significant in-vitro and in-vivo cytotoxic, anti-tumour and anti-proliferative activity in various cell lines and tumor cells which indicate the considerable potential of Calotropis procera for anticancer adjutants. The objective of the presentr eview is to provide systematic information about the phytochemical and various extracts of Calotropis procera as potential candidate for cancer treatment.



  1. Elisabetsky. Plants used as analgesics by amazoniancabocols. Int J crude drug Res. 1990;28:309-320.
  2. Bhatti GR, Qureshi R, Shah M. Ethnobotany of Calotropisprocera with especial reference to the people of Nara Desert. Scientific Sindh, Pub. Salu, Khairpur. 1998.
  3. Mukherjee B, Bose S, Dutta SK. Phytochemical and pharmacological investigation of fresh flower extract of Calotropisprocera Linn. IntJPharmaSci Res. 2010;1:182-187.
  4. Sharma AK, Kharb R, Kaur R. Pharmacognostical aspects of Calotropisprocera (Ait.) R. Br. Int J Pharm Bio Sci 2011;2:480-8.
  5. Anonymous, The Wealth of India, Raw Materials. CSIR, New Delhi. 1982.
  6. Chatterjee A, Chandra PS. The treatise of Indian medicinal plants. CSIR, New Delhi. 1995.
  7. Meena AK, Yadav AK, Niranjan US, Singh B, Nagariya AK, Sharma K. A review on CalotropisproceraLinn and its ethnobotany, phytochemical, pharmacological profile. Drug Invent Today. 2010;2:185-90.
  8. Quazi S, Mathur K, Arora S. Calotropisprocera: An overview of its phytochemistry and pharmacology. Indian J Drugs. 2013;1:63-9.
  9. Murti Y, Yogi B, Pathak D. Pharmacognosticstandardisation of leaves of Calotropisprocera (Ait.) R. Br. (Asclepiadaceae). Int J of Ayurveda Res. 2010;1:14-17
  10. Gupta S, Gupta B, Kapoor K, Sharma P. Ethnopharmocological potential of Calotropisprocera: An overview. Int Res J Pharm. 2012;3:19-22.
  11. MeenaAk, Yadav AK, NiranjanUS,et al. A Review on Calotropisprocera Linn and its Ethnobotany, Phytochemical, Pharmacological profile. Drug Invent Today 2010;2:185-190.
  12. Karale PA, karale MA. A Review on Phytochemistry and Pharmacological properties of milkweed family herbs (asclepiadaceae). Asian J Pharm Cli Res. 2017:10;27-34
  13. Yelne MB, Sharma PC, Dennis TJ. Database on Medicinal Plants used in Ayurveda, Central Council for Research in Ayurveda and Siddha, New-Delhi. 2000.
  14. Bairagi SM, GhuzePrashant, GilhotraRitu. Pharmacology of Natural Products: An recent approach on CalotropisgiganteaandCalotropisprocera. Ars Pharm. 2018;59(1):37-44
  15. Evans WC, Evans D, Trease GE. Trease and EvansPharmacognosy.Edinburg, New York. Saunders/Elsevier. 2005.
  16. Majumder PK, Kumar VL. Antiinflammatory activity of fractions of latex of Calotropisprocera in carrageenan induced rat Paw oedema. PhytoTher Res. 1997;11(2):166-167.
  17. Roy S, Sehgal R, Padhy BM, Kumar VL. Antioxidant and protective effect of latex of Calotropisproceraagainstalloxan-induced diabetes in rats. J Ethnopharmacol. 2005;102(3):470-473.
  18. Dewan S, Kumar S, Kumar VL. Antipyretic effect of latex of Calotropisprocera. Ind J Pharmacol. 2000a;32:252-253.
  19. Larshini M, Markouk M, Jaouhari JT, Lazreck HB, Jana M. The antipyretic activity of some Moroccan medicinal plants. PhytoTher. 2002;16:97-98.
  20. Sehgal R, Roy S, Kumar VL. Evaluation of cytotoxic potential of latex of CalotropisproceraandPodophyllotoxin in Allumceparoot model. Bio cell. 2006;30:9-13.
  21. Choedon T, Mathan G, Arya S, Kumar VL, Kumar V. Anticancer and cytotoxic properties of the Calotropisprocera in a transgenic mouse model of hepatocellular carcinoma. World J Gastroenterol. 2006;12:2517-2522.
  22. Hemerson IF, Magalhes Paulo MP, Ferreira Eraldo S, MouraMárcia R, Torres Ana PNN, AlvesOtília DL, et al. In vitro and in vivo antiproliferative activity of Calotropisprocera stem extracts. Anais da Academia Brasileira de Ciências. 2010;82:407-416.
  23. Yesmin N, Uddin SN, Mubassara S, Akond MA. Antioxidant and Antibacterial Activities of Calotropisprocera Linn. Am-Euras J Agric Environ Sci. 2008;4:550-553.
  24. Kumar VL, Roy S. Calotropisprocera latex extract affords protection against inflammation and oxidative stress in Freund’s complete adjuvant-induced monoarthritis in Rats. Mediators Inflamm. 2007;1:1-7.
  25. Basu A, Nag Chaudhuri AK. Preliminary studies on the anti-inflammatory and analgesic activities of Calotropisproceraroot extract. J Ethnopharmacol. 1991;31:319-324.
  26. Jalalpure SS. Anticonvulsant effects of Calotropisproceraroot in rats. Pharm Bio. 2009;47:162-167.
  27. Kuta FA. Antifungal effect of Calotropisprocerastems bark on EpidermophytonflocosumandTrichophytongypseum. African J Biotech. 2008;7:2116-2118.
  28. Sharma N, Jacob D. Inhibition of fertility and functional alteration in the genital organs of male Swiss albino mouse after administration of Calotropisproceraflower extract. Pharma Bio. 2001;39:403-407.
  29. Al-Qarawi AA, Mahmoud OM, SobaihHaroun EM, Adam SE. A preliminary study on the activity of Calotropisproceralatex against Haemonchuscontortus infection in Najdisheep. Vet Res Commun. 2001;25:61-70.
  30. Setty SR, Quereshi AA, Swamy AHMV, Patil T. Prakash T, Prabhu K, Gouda AV. Hepatoprotective activity of Calotropisproceraflowers against paracetamol-induced hepatic injury in rats. Fitoterapia. 2007;78:451–454.
  31. Kumar VL, Sangraula H, Dewan S, Kumar S. Anti-diarrheal activity of the latex of Calotropisprocera. J Ethnopharmacol. 2001;76:115-118.
  32. Sharma P, Sharma JD. Evaluation of in-vitroschizonticidal activity of plant parts of Calotropisprocera-an ethnobotanical approach. J Ethnopharmacol. 2000a;68:83-95.
  33. Joshi H, Havanavar V, Gavimat C, Praveena PH. Investigation on the Alzheimer´s potential of Calotropisprocerain mice Alzheimers Dement. 2008;4:502-510
  34. Kumar VL, Shivkar YM. In-vivo and in-vitro effect of latex of Calotropisprocera on gastrointestinal smooth muscles. J Ethnopharmacol. 2004;93:377-379.
  35. Sharma K, Kharb R, Kaur R. Pharmacognostical aspects of Calotropisprocera(Ait.) R.Br. Int J Pharm Bio Sci. 2011;2:1-9.
  36. Ahmed KK, Rana AC, Dixit VK. Calotropisspecies (Ascelpediaceae): A comprehensive review. Pharmacogn Mag. 2005;1:48-52.
  37. Mijatovic T Anne, Op De Beeck, Eric van Quaquebeke, JaniqueDewelle, Francis Darro,Yvan de Launoit, Robert Kiss. The Cardenolide UNBS1450 is able to deactivate nuclear fact κB-mediated cytoprotective effects in human non-small cell lung cancer cells. Mol Cancer Therapeu. 2006;5:391-399.
  38. Upadhyay RK. Ethnomedicinal, pharmaceutical and pesticidal uses of Calotropisprocera(Aiton) (Family: Asclepiadaceae). Int J Green Pharm. 2014;8:135-46.
  39. Kumar VL, Arya S Ed. Medicinal uses and pharmacological properties of Calotropisprocera. Texas: Studium Press. 2006;373‑388.
  40. Fabiano Teixeira M, Ramos MV, Soares AA, etal.In-vitrotissue culture of the medicinal shrub Calotropisprocerato produce pharmacologically active proteins from plant latex. Process Biochem. 2011;46:1118-1124
  41. HemersonMagalhes IF, Ferreira PMP, Moura ES, etal.In-vitroandin-vivoanti-proliferative activity of Calotropisprocerastem extracts. An Acad Bras Sci. 2010;82:407-416.
  42. SeetharamaiahNalini ,Nandini S, Suresh GS, et al, An electrochemical perspective assay for anticancer activity of Calotropisprocera against glioblastoma cell line (LN-18) using Carbon nanotubes- graphenenano- conglomerate as a podium. Adv Mater Lett 2016;7:1003-1009.
  43. Sehgal R, Roy S, Kumar Vl. Evaluation of cytotoxic potential of latex of Calotropisprocera and Podophyllotoxin in Allumceparoot model. Bio Cell. 2006;30:9-13
  44. Sagadevan Suresh, Selvaraj V, Lakshmipathy M, etal.Exploring the therapeutic potentials of phytomediated silver nanoparticles formed via Calotropisprocera (Ait.) R. Br. root extract†J ExpNanosci. 2020;15:217–232.
  45. Mathur R, Gupta SK, Mathur SR, Velpandian T. Anti-tumor studies with extracts of Calotropisprocera (Ait.) R.Br. root employing Hep2 cells and their possible mechanism of action. IndJExp Bio. 2009;27:343-348.
  46. Verma SK., Singh SK., Mathur A. In-vitrocytotoxicity of CalotropisproceraandTrigonellafoenumgraecumagainst human cancer cell lines. J Chem Pharm Res. 2010;2:861-865.
  47. Samy RP, Rajendran P, Li F, et al. Identification of a Novel Calotropisprocera Protein That Can Suppress Tumor Growth in Breast Cancer through the Suppression of NF-kB Pathway. PLOS ONE. 2012;7:48514.
  48. Murti Y, Sharma S, Mishra P. In-VitroCytotoxicity of Chromatographic Elutes of Calotropisprocera(Ait.) R BR. leaves Against Human Hepatoma Cell Line (HEPG2). Indian Drugs. 2016;53:48-52.
  49. Oliveira JS, Costa-Lotufo VL, BezerraDP,etal.In-vivo growth inhibition of sarcoma 180 by latex proteins from Calotropisprocera. Naunyn-Schmied Arch Pharmacol. 2010;382:139–149.
  50. De Oliveira JS, Bezerra DP, de Freitas CDT, et al.In-vitro cytotoxicity against different human cancer cell lines of laticifer proteins of Calotropisprocera(Ait.) R. Br. Toxicol in Vitro. 2007;21:1563–1573.
  51. Choedon Tenzin, Ganeshan M, Soneera A, Kumar VL. Anticancer and cytotoxic properties of the latex of Calotropisprocera in a transgenic mouse model of hepatocellular carcinoma. World J Gastroenterol.2006;12:2517-2522.
  52. Oliveira JS, Costa-Lotufo LV, Bezerra DP, et al. In vivo growth inhibition of sarcoma 180 by latex proteins from Calotropisprocera. NaunynSchmiedebergs Arch Pharmacol. 2010;382:139-49.
  53. Prabha MR, Vasantha K. Antioxidant, cytotoxicity and polyphenolic content of Calotropisprocera(Ait.) R Br Flowers. J Appl Pharm Sci. 2011;1:136.
  54. Hassan SwedAlzahrani, Safar AAlmalki, Mohamed R Rizgallah. Study of the cytotoxic effect of Calotropisprocera on Breast Cancer Cell Line T47D in Vitro: A Traditional Remedy. Inter J Scientific Innov. 2019;7:107-112.
  55. BhagatMadhulika and Sharma Vikas. Anti-cancer Activity of Arka (Calotropisprocera) on HCT-15 Cancer Cell Line. Inter J Med Sci. 2010; 2:152-154.
  56. Parhira S, Zhu GY, Chen M, Bai LP, Jiang ZH. Cardenolides from Calotropisgiganteaas potent inhibitors of hypoxia-inducible factor-1 transcriptionalactivity. J Ethnopharmacol. 2016;194:930-6.
  57. Kanojiya S, Madhusudanan KP. Rapid identification of calotropagenin glycosides using high-performance liquid chromatography electrospray ionisation tandem mass spectrometry. Phytochem Anal. 2012;23:117-125.
  58. Ibrahim SR, Mohamed GA, Shaala LA, etal.Proceraside A, a new cardiac glycoside from the root barks of Calotropisprocerawithin vitro anticancer effects. Nat Prod Res. 2014;28:1322-7.
  59. Tian L, Xie XH, Zhu ZH. Calotropin regulates the apoptosis of non-small cell cancer by regulating the cytotoxic T-lymphocyte associated antigen 4- mediated TGF-β/ERK signaling pathway. Mol Med Rep. 2018;17:7683-91.
  60. Ibrahim SR, Mohamed GA, Shaala LA, Banuls LM, Kiss R, Youssef DT. Calotroposides H-N, new cytotoxic oxypregnaneoligoglycosides from the root bark of Calotropisprocera. Steroids. 2015;96:63-72.
  61. Ibrahim SR, Mohamed GA, Shaala LA, etal.Calotroposide S, new oxypregnaneoligoglycoside from Calotropisproceraroot bark. Res Nat Prod. 2016;10:761.
  62. Ibrahim SR, Mohamed GA, Shaala LA, etal.Newursane-type triterpenes from the root bark of Calotropisprocera.PhytochemLett. 2012;5:490-495.
  63. Kushwaha VB, Singh A. Effect of uscharin on the reproduction of the snail Lymnaeaacuminata. World J Zool. 2010;5:15-9.
  64. Shaker KH, Morsy N, Zinecker H, et al.Secondary metabolites from Calotropisprocera(Aiton). PhytochemLett. 2010;3:212-6.
  65. Van Quaquebeke E, Simon G, Andre A, et al. Identification of a novel cardenolide (2’’-oxovorusharin) from Calotropisprocera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: structure–activity relationship analyses. J Med Chem.2005;48:849–856.
  66. Kiss R, Mijatovic T, Van Quaquebeke E, Darro F. Cardenolides: old drugs with new applications in oncology. American Association for Cancer Research. Washington DC, April 1–5.
  67. Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer. 2005;5:886–897.
  68. Rajasekaran SA, Barwe SP, Rajasekaran AK. Multiple functions of Na,K-ATPase in epithelial cells. SeminNephrol.2005;25:328–334.
  69. Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R. Cardenolides on the road to anticancer therapy. BBA-Reviews Cancer. 2007b;1776:32–57
  70. Mijatovic T, Lefranc F, Camby I, Dewelle J, Van Quaquebeke E, Darro F, Kiss R. Cardenolide-related UNBS1450 compound target the Src kinase in the Na1/K1-ATPase signalosome and exert potent in vitro and in vivo anti-tumor activities in experimental human glioblastomas. American Association for Cancer Research Annual Meeting, Minisymposia, 2005, April 16–20.
  71. Mijatovic T, Lefranc F, Quaquebeke EV, Vynckt FV, Darro F, Kiss R. UNBS1450: A New Hemi-Synthetic Cardenolide with Promising Anti-Cancer Activity. Drug Develop Res. 2007;68:164–173.
  72. Dmitrieva R. Doris PA. Cardiotonic steroids: potential endogenous sodium pump ligands with diverse function. Exp Bio Med. 2002;227:561-569.
  73. Schoner, W. Endogenous cardiac glycosides, a new class of steroid hormones. EurJBiochem. 2002;269:2440-2448.
  74. Staroske T, Hennig L, Welzel P. Synthesis and pharmacological properties of cardenolides substituted at the butenolide part. Tetrahedron.1996;52:12733-12744.
  75. Bereta J, Cohen MC, Bereta M. Stimulatory effect of ouabain on VCAM-1 and iNOS expression in murine endothelial cells: involvement of NF-kappaB. FEBS Lett.1995;377:21-25.
  76. Aizman O, Uhlen P, Lal M, Brismar H, Apeira A. Ouabain, a steroid hormone that signals with slow calcium oscillations. ProcNatlAcadSci USA. 2001;98:13420-13424.
  77. Scheiner-Bobis G, Schoner W. A fresh facet for ouabain action. Nat Med.2001;7:1288-1289.
  78. Miyakawa-Naito A, Uhlen P, Lal M, Aizman O, Mikoshiba K, Brismar H, Zelenin S, Aperia A. Cell signaling microdomain with Na,K-ATPase and inositol 1,4,5-triphosphate receptor generates calcium oscillations. J Biol Chem.2003;278:50355-50361.
  79. Srenivasan Y, Sarkar A, Manna SK. Oleandrin suppresses activation of nuclear transcription factor-kappa B and activator protein-1 and potentiates apoptosis induced by ceramide. BiochemPharmacol.2003;66:2223-2239.
  80. Joshi R, Sharma A, Jat BL. Analysis of antioxidant activity in extracts of Calotropisprocera(Ait). R Br J ApplBiosci. 2009;17:899-903.

How to Cite

Verma, J. (2021). Anticancer Potential of Calotropis procera: An Overview. Discovery Phytomedicine - Journal of Natural Products Research and Ethnopharmacology, 8(2).




Search Panel